Tumor suppressive activity of anti-CD274 antibody as an immune checkpoint inhibitor for cervical cancer mouse model

被引:0
|
作者
Murakami, Kazuyuki [1 ]
Yoshino, Naoto [2 ]
Kawamura, Hanae [1 ]
Sasaki, Yutaka [2 ]
Kagabu, Masahiro [1 ]
Muraki, Yasushi [2 ]
Sugiyama, Toru [1 ]
机构
[1] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate, Japan
[2] Iwate Med Univ, Sch Med, Div Infect Dis & Immunol, Dept Microbiol, Morioka, Iwate, Japan
关键词
D O I
10.1016/j.jri.2015.09.059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
56
引用
收藏
页码:139 / 139
页数:1
相关论文
共 50 条
  • [1] A combined effect of immune checkpoint inhibitors and a CD40 agonistic antibody in a pancreatic cancer mouse model
    Ichikawa, Juri
    Kawano, Kuniyuki
    Kato, Shingo
    Kurotaki, Daisuke
    Kuroishikawa, Ryo
    Kawase, Wataru
    Yoshida, Haruka
    Hiroshima, Yukihiko
    Endo, Itaru
    Maeda, Shin
    Nakajima, Atsushi
    Tamura, Tomohiko
    CANCER SCIENCE, 2024, 115 : 763 - 763
  • [2] Immune checkpoint inhibitor treatment for peritoneal metastasis of gastric cancer in immune competent mouse model
    Du, Wanying
    Masuda, Hiroki
    Nagaoka, Koji
    Yasuda, Tomohiko
    Kuge, Komei
    Seto, Yasuyuki
    Kakimi, Kazuhiro
    Nomura, Sachiyo
    CANCER SCIENCE, 2023, 114 : 1184 - 1184
  • [3] Tumor suppressive effect of anti-PD-1 antibody against angiosarcoma in a mouse model
    Sekiguchi, Akiko
    Ishikawa, Mai
    Fujiwara, Chisako
    Inoue, Yuta
    Yamazaki, Sahori
    Uchiyama, Akihiko
    Motegi, Sei-ichiro
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2022, 105 (01) : 58 - 60
  • [4] Anti-tumor activity of a fully human anti-CD27 monoclonal antibody in a transgenic mouse model
    Thomas, Lawrence J.
    He, Li-Zhen
    Forsberg, Eric M.
    Vitale, Laura
    Boyer, James M.
    Jones, Kristen L.
    Weidlick, Jeffrey
    Glennie, Martin J.
    Keler, Tibor
    Marsh, Henry C.
    CANCER RESEARCH, 2011, 71
  • [5] Cannabinoid receptor 2 creates a suppressive tumor immune microenvironment in a mouse model of lung cancer and predicts responsiveness to anti-PD-1 antibody treatment
    Sarsembayeva, A.
    Kienzl, M.
    Gruden, E.
    Ristic, D.
    Kargl, J.
    Schicho, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 78 - 79
  • [6] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models
    Rolland, S.
    Klinz, S. G.
    Meyer-Losic, F.
    Nahkle, J.
    Delille, R.
    de Boisferon, M. Hillairet
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Budhu, Sadna
    Giese, Rachel
    De Henau, Olivier
    Zappasodi, Roberta
    Campesato, Luis Felipe
    Gupta, Aditi
    Barker, Christopher
    Freimark, Bruce
    Wolchok, Jedd D.
    Merghoub, Taha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [8] Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Budhu, Sadna
    De Henau, Olivier
    Zappasodi, Roberta
    Giese, Rachel
    Campesato, Luis F.
    Barker, Christopher
    Freimark, Bruce
    Hutchins, Jeff
    Wolchok, Jedd D.
    Merghoub, Taha
    CANCER RESEARCH, 2017, 77
  • [9] Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Budha, Sadnu
    Giese, Rachel
    Gupta, Aditi
    De Henau, Olivier
    Zappasodi, Roberta
    Campesato, Luis Felipe
    Barker, Christopher
    Shan, Joseph
    Wolchok, Jedd D.
    Merghoub, Taha
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [10] IMMUNE CHECKPOINT INHIBITOR COMBINED WITH THE GROWTH INHIBITOR LYCORINE SYNERGISTICALLY FUNCTION TO MEDIATE ANTI-TUMOR EFFECTS IN A MOUSE MODEL OF RENAL CELL CARCINOMA
    Li, Xiezhao
    Xu, Naijin
    Xu, Aibai
    Watanabe, Masami
    Huang, Peng
    Nasu, Yasutomo
    Liu, Chunxiao
    JOURNAL OF UROLOGY, 2017, 197 (04): : E963 - E963